SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon inches up on entering into share subscription agreement with BBIL, Activ Pine LLP

10 Jan 2020 Evaluate

Biocon is currently trading at Rs. 282.75, up by 0.45 points or 0.16% from its previous closing of Rs. 282.30 on the BSE.

The scrip opened at Rs. 284.15 and has touched a high and low of Rs. 285.30 and Rs. 281.40 respectively. So far 53132 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 341.43 on 25-Jan-2019 and a 52 week low of Rs. 211.30 on 20-Aug-2019.

Last one week high and low of the scrip stood at Rs. 302.00 and Rs. 275.05 respectively. The current market cap of the company is Rs. 33948.00 crore.

The promoters holding in the company stood at 60.67 % while Institutions and Non-Institutions held 20.76 % and 18.58 % respectively.

Biocon, Biocon Biologics India (BBIL) and Activ Pine LLP (an affiliate of True North Fund VI LLP) have executed a share subscription agreement and a shareholder agreement. The Company currently holds 93.27% of the share capital of BBIL, on a fully diluted basis. Pursuant to the agreement, True North Fund VI LLP shall subscribe to 50.25 lakh equity shares of BBIL, at a price of Rs 1,067.07 per equity share.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

428.00 9.10 (2.17%)
03-Jul-2026 15:36 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1370.35
Cipla 1457.05
Zydus Lifesciences 1139.60
Lupin 2479.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: